Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the XP1100RF Therapy on Thighs Circumference Reduction

NCT02527369 is registered in ClinicalTrials.gov with BTL Industries Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02527369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the XP1100RF Therapy on Thighs Circumference Reduction
Lead sponsor
BTL Industries Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2014
Completion date
March 31, 2015
Enrollment
38 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

subcutaneous fat cell disruption, thighs circumferential reduction